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Summary.-The antigen specific cell mediated cytotoxicity of MSV immune spleen
lymphocytes to 51Cr labelled murine lymphoma cells was wholly abolished by
pretreatment of the spleen cells with anti-0 antibody and complement. Early
during the immune response to MSV the cytotoxic activity was inhibited by incuba-
tion of immune lymphocytes with "late progressor" or "early regressor" serum.
Immune lymphocytes at later times were more refractory to such inhibition by
serum blocking factors.
Although unfractionated cytotoxic lymphocytes, irrespective of the time after
MSV infection at which they were tested, were inhibited by soluble tumour associated
antigen (TAA), a subpopulation of cytotoxic T cells was identified which was in-
hibited neither by antigen nor serum.
THE NATURAL history and immune
response to tumours induced by Moloney
mouse sarcoma virus (MSV(MLV-M)) in
Balb/c mice have been studied extensively.
In adult animals, tumours generally
develop at the site of injection within
5-8 days and reach a maximum size in
about 10-15 days (Fefer et al., 1968).
Most tumours subsequently regress, the
regression usually being complete by
25 days (Fefer et al., 1968; Lamon et
al., 1972).
Several workers have demonstrated
syngeneic cell mediated cytotoxicity
(CMC) in this system (Hellstrom and
Hellstrom, 1969; Lamon et al., 1973;
Leclerc et al., 1973; Plata and Levy,
1974). CMC by both T and non-T
lymphocytes has been detected in a
microcytotoxicity (MCA) assay (Lamon et
al., 1973). Cytotoxic T cells were found
immediately before tumour development
and during regression, but disappeared
after 30 days. The cytotoxic non-T cell
population, however, although also present
before the tumour had appeared and
during regression, was most active at
30 days and was still active at Day 60.
Neither T nor non-T cells were active
at the time of peak tumour size (Lamon et
al., 1973).
In contrast, the peak cytolytic activity
in a chromium release test (CRT), which,
as in allogeneic systems, measures exclu-
sively T cell cytotoxicity was found at
about Day 15 (Cerottini, Nordin and
Brunner, 1970; Leclerc et al., 1973). The
differences in cytotoxic T cell kinetics in
CRT and MCA have been confirmed
using the same immune lymphoid cell
preparations in both assays (Plata and
Levy, 1974). In a similar rat lymphoma
system, the cytotoxicity of immune T
cells can be increased by incubation in
vitro (de Landazuri and Herberman,
1972). Since the MAICA measures a long-
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term effect, in contrast to the short term
CRT, the apparent spontaneous activity
of immune T cells in this assay may
merely reflect the potential of cells
activated in vitro. Furthermore, since
killing by non-T cells in the MCA does
not occur in the absence of B cells (Lamon
et al., 1973), this effect may be mediated
by Fc receptor bearing non-immune cells
in the presence of sensitizing antibody
(Maclennan, Loewi and Harding, 1970).
Immune T lymphocytes, however, are
specifically sensitized to tumour asso-
ciated antigens in MSV regressor mice
(Gorczynski, 1974a; Knight and Gorezyn-
ski, 1975), and these immune T cells
can aid in tumour rejection (Gorczynski,
1974b; Gorczynski and Norbury, 1974).
Of equal interest to the question of
the nature ofthe immunologically reactive
cells in tumour bearing (and regressor)
mice, is the question of the role of specific
and nonspecific immunosuppressing fac-
tors in these animals. Earlier studies in
the MSV system suggested that pro-
gressor animals contained factors in the
serum able to block the cytotoxicity in
vitro of progressor and regressor lympho-
cytes (Hellstrom and Hellstrom, 1969).
Evidence was presented that such block-
ing factors in tumour bearer animals
were antigen-antibody complexes (Sjo-
gren et al., 1971). Using a more quantita-
tive 51Cr cytotoxicity assay, Leclerc et
al. (1973) were unable to reproduce
these findings. Moreover, it has recently
become apparent that progressor animals
contain a cell population able to block
the in vitro activity of T lymphocytes
in a nonspecific manner (Gorczynski,
1974c). It has been suggested that this
type of effect could still be mediated
via antigen-antibody complexes (Gorczyn-
ski et al., 1974) and evidence to support
this contention has recently been pre-
sented (Gorczynski et al., 1975). There
is at present only circumstantial evidence
that specific and nonspecific blocking
factors analysed in vitro have any rele-
vance to the in vivo tumour situation.
One other area which we at present
know little about is the role of virus
coded antigens in the immune response
to virally induced tumours. There is
now evidence that both virus coded
antigens (e.g. viral envelope antigen,
VEA) and a virus induced antigen with
viral group specificity exist as tumour
associated surface antigens (TASA) in
the avian RNA tumour virus situation
(Gelderblom, Bauer and Graf, 1972) and
in the MSV tumour situation (Eckner
and Steeves, 1972; Aoki et al., 1972;
Yoshiki et al., 1974). Lymphocytes reac-
tive to the two avian TASA (Kurth and
Bauer, 1972) have been detected by
microcytotoxicity tests. In a rat MLV-G
induced lymphoma system, cytotoxic anti-
body is directed principally, and immune
lymphocytes partially, against the internal
virion antigen, p30 (Shellam and Knight,
1974; Knight et al., 1974). In the
murine MSV system there is evidence
that p30 is the main tumour rejection
antigen (Gorczynski and Knight, 1975).
Furthermore, lymphocytes reactive both
to this antigen and to the viral envelope
glycoprotein antigens (VEA) have been
detected by lymphocyte transformation
tests (Knight and Gorczynski, 1975).
We have developed a 51Cr cytotoxicity
assay for lymphoid cells from MSV
inoculated mice with a view to answering
several questions of fundamental im-
portance. We wished to examine the
kinetics of the development of cell medi-
ated cytotoxicity, the cell(s) responsible
for this lysis and the relationship between
these cell types and those described using
alternative assays for immunity in this
system. Finally, we have examined the
ability of purified viral antigens and
serum taken from mice at different
times post MSV inoculation to block
direct cell mediated cytotoxicity caused
by different populations of effector cells.
MATERIALS AND METHODS
Mice. Male Balb/c and C57BI/Blue (here-
after referred to as C57B1 for clarity) were
obtained from the ICRF breeding unit at
Mill Hill.
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Turmours and in vivo sensitization.-Sar-
comata were induced in 30-day old Balb/c
mice by injection in the thigh of 0 1 ml
crude MSV tumour homogenate as described
earlier (Gorczynski, 1974a). An MSV de-
rived lymphoma wNas obtained by passaging
MSV transformed fibroblasts once through
young Balb/c mice before establishing the
transformed cells as an in vitro suspension
culture. The medium used for such cultures
was Dulbecco's modified Eagle's medium
(with added glutamine, penicillin and strepto-
mycin) supplemented with 10% foetal calf
serum, DF10. The cells were cultured in
DF10 and grew with a doubling time of
8-10 h provided the concentration was kept
below 1 x 106/ml. The harvested cells pro-
vided excellent reproducible targets for the
cytotoxic assay (see below). This cell line
(subsequently referred to as SDLC) grew in
vivo in Balb/c as an ascitic tumour. Balb/c
mice were sensitized to C57B1 alloantigens
by inoculation of 50 x 106 C57B1 spleen
cells intraperitoneally 18-20 days before
sacrifice of the Balb/c.
Cell preparation.-Spleen cells were pre-
pared by teasing the organs apart in ice-cold
phosphate buffered saline (PBS). Cell
clumps were allowed to settle out for 10 min
at 4°C and the cells centrifuged at 200 g
for 5 min at 4°C. The cells were then
resuspended in PBS writh 0.1% bovine
serum albumin (BSA) or DF1o, depending
on the subsequent manipulations to be
performed with them. Unless otherwise
stated, all cell concentrations refer to viable
nucleated cells determined by trypan blue
dye exclusion.
Velocity sedimentation cell separation.-
This technique, which separates cells pri-
marily according to their size, has been
described elsewhere (Miller and Phillips,
1969). Sterile glass chambers, either 11-0 cm
or 16-8 cm in diameter (Aimer Glass Co.,
London, England) were used according to
the number of cells to be separated. The
initial cell band was loaded in 0-30% BSA
in PBS, the total cell concentration (viable
and non-viable) being no greater than
10 X 106/ml.
Antisera and treatment of cells with
antisera. The preparation of 2 rabbit anti-
sera, anti-mouse brain associated theta
(anti-Br-0) and anti-immunoglobulin (anti-Ig)
are described in detail elsewhere (Gorezynski,
1974b). Also in this report are data con-
firming the specificity of these 2 antisera,
in the presence of guinea-pig complement,
for cytotoxicity to murine T or B lympho-
cytes respectively. Thus, the anti-Br-6
killed 70% of murine peripheral lymph
node cells, 100% of mouse thymocytes and
removed the PHA responsive cells (but not
the LPS responsive cells) from a mouse
spleen cell suspension. In addition, the
anti-Br-0 removed the T helper cell activity
for an anti-sheep erythrocyte (SRBC) anti-
body response while not affecting the B cell
response to a thymus independent antigen
(polymerized flagellin, POL). In contrast,
the anti-Jg did not kill appreciable numbers
ofthymocytes or remove the PHA responsive
cells from a mouse spleen cell suspension,
or affect T helper cells for an anti-SRBC
response. However, the anti-Ig did remove
LPS responsive cells from a spleen cell
suspension and did remove B cells responding
to both thymus dependent (SRBC) and
thymus independent (POL) antigens.
Cells to be treated with either antiserum
were suspended in 0-1% BSA in PBS, with
the final concentration of anti-serum present
being 1/15 (anti-Br-0) or 1/10 (anti-Ig). The
cells were incubated for 90 min at 4°C,
washed (200 g for 5 min at 4°C), resuspended
in either DF10 or guinea-pig complement
(diluted 1/10 in DF10), and ineubated for
a further 45 min at 37°C. The cells were
then rewashed as above and used as described
in the text.
Cytotoxicity assay.-5 to 10 x 106 SDLC
cells were radiolabelled in 1 ml DF10 con-
taining 100,uCi 51Cr (as sodium chromate,
Radiochemical Centre, Amersham, England)
for 60 min at 37°C in 10% CO2 in air. The
cells were washed 4 times in 25 ml DF1O
(at room temperature). They were then
resuspended in 25 ml DF10 and incubated
at 37°C in 10% CO2 in air for a further
3-4 h before use as targets in the cytotoxic
test. We found that this preincubation
of the labelled target cells dramatically
reduced their spontaneous release during
the assay period and allowed the latter to
be performed for 15 h with acceptably low
spontaneous 51Cr release. Immediately be-
fore use in the assay the cells were washed
once as above and suspended to a concentra-
tion of 5 x 105/ml. 5 x 104 51Cr labelled
SDLC cells were then mixed with varying
numbers of the effector cells under test in
1 ml DF10, in glass bacteriological test
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tubes (5 x 0-8 cm). All groups were assayed
in triplicate.
After incubation without rocking for 15 h
at 37°C in a humidified atmosphere of 10%
C02 the tube contents were mixed and
the tubes centrifuged at 1000 g for 10 min
at room temperature. The supernatants
were counted in a well type gamma counter
(Wallac GTL, Wallac, Turku, Finland).
All experiments contained control groups
of target cells incubated with either medium
alone (background) or with 5% BRIJ
(polyoxyethylene lauryl ether) detergent
(maximum releasable 51Cr). Detergent re-
lease was routinely 80-85% of the total
51Cr in the cell suspension. The back-
ground release was ofthe order of1-0-196%/h.
Specific 51Cr release was calculated according
to the formula:
Specific 51Cr (%)
100 X experimental-background
detergent release-background
All data in the text are given as an arithmetic
mean ± standard error of the mean.
Mouse sera.-Mouse blood was collected
by cardiac puncture. The serum was heat
inactivated (56°C for 30 min) and stored
at -20°C until use.
Rabbit anti-mouse immunoglobulin columns
(anti-MIg columns).-Rabbit anti-MIg
columns were prepared as described pre-
viously (Kilburn, Smith and Gorczynski,
1974). The maximum capacity of the
column used was found experimentally to
be 2 mg mouse immunoglobulin. Mouse
serum was absorbed on these columns at pH
7 0 in PBS, 0 3 ml serum being washed on to
the column with 1 ml PBS. The column
was left at room temperature for 30 min
and then washed with PBS until the O.D.
280 nm was less than 0 05. Absorbed
immunoglobulin was eluted at pH 2-6 with
HCL glycine buffer. The pH of the eluted
immunoglobulin was adjusted to 7 0 with
phosphate buffer. The unabsorbed effluent
and the eluted material were concentrated
by vacuum dialysis and then dialysed
against 200 volumes of PBS for 24 h.
Preparation of viral antigens used for
blocking studies.-The preparation of purified
MSV(M) virus, disrupted MSV(M) or MSV(G)
virus, viral envelope antigen (VEA), and
p30 protein (gs antigen) have been described
elsewhere (Knight and Gorczynski, 1975).
In addition, papain digests of tumour cells
from MSV-M infected mice (C-Vgs) were
prepared by the method of Law and Appella
(1973).
Protein concentration.-Protein concen-
tration was estimated by the method of
Lowry et al. (1951).
RESULTS
Kinetics of development of cytotoxicity to
SDLC
In order to investigate the time of
appearance of specifically cytotoxic cells
in MSV infected mice, spleen cells were
taken from mice at different times after
MSV infection. At least 5 mice were
used for each time point to prepare a
pool of spleen cells, and the cells were
tested at various cell concentrations with
a standard number of 5'Cr-SDLC target
cells. The percent specific lysis (together
with the relative total mean nucleated
cell number per spleen) at a 100 : 1
effector : target cell ratio is shown in the
lower panel of Fig. 1. It should be
noted that, as with the assay for allo-
sensitized effector cells in mice (Cerottini
et al., 1970) this 5'Cr assay shows a
semi-logarithmic relationship between per-
cent specific lysis and effector : target
cell ratio. As an example, the upper
panel of Fig. 1 shows this for one day
of assay, 11 days post MSV. The same
relationship was observed at all time
points.
There are several features of interest
inthesedata. Firstly,unlikeothersystems,
e.g. the rat W/Fu lymphoma system (de
Landazuri and Herberman, 1972), non-
immunized animals have no cytotoxic
cells. Even at a ratio of 600 : 1, no
cytotoxicity by normal cells was detected.
Secondly, in contrast to the findings of
Leclerc (Leclerc et al., 1973), two major
peaks of activity were observed; the
first some 10-12 days post MSV injection
(when the tumour was in its progressive
phase of growth) and a second broader
peak, 22-30 days post MSV, after the
tumour had regressed. This biphasic
response closely parallels the kinetics
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FIG. 1.-Specific cytotoxicity to 51Cr-SDLC target cells of spleen cells taken from mice at different
times post MSV. Five mice were used at each time of assay to prepare a spleen cell pool aind
cell mecilated cytotoxicity to 51Cr SDLC cells determined as described in the text and Materials
and AMethods. All dlata points in the lower panel represent the arithmetic mean (± standard
error) of the cytotoxicity at a 100: 1 effector: target ratio. Samples were set up in triplicate.
The mean nucleated cell numbers per spleen (x 108) is shown in brackets. The upper panel
of the figure shows a titration of the activity from Day 11 MSV spleen- similar titration curves
(showing a linear relationship between percent specific release and log effector cell number) could
be (Irawn for all (lays of assay.
of T cell cytotoxicity measured in the
MCA assay (Lamon et al., 1972). In
other assays for T cell immunity, however,
(lymphocyte transformation and macro-
phage migration inhibition) the decline
in activity occurred between days
9-14, when the tumour was growing
progressively (Gorczynski, 1974a, c).
These findings will be discussed in detail
later.
Specificity and nature of effector cells
mediating cytotoxicity to SDLC cells
In order to examine the specificity
of killing in this system we have analysed
the ability of mice carrying a different
type of syngeneic tumour, or alloimmun-
ized mice, to kill SDLC cells or cells
bearing the relevant alloantigens. Spleen
cells were harvested from 5 Balb/c mice
20 days after subcutaneous inoculation
8) .5)
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Fic. 2. Specificity of cytotoxicity by MISV immune lymphocytes. The effector cells tested (at
the ratios shown) were from AISV infected mice (circles), C57B1 immunizedl mice (triangles), or
polyoma virus infectedl mice (squares). The upper panel shows the cytotoxicity to 51Cr normal
spleen cells of C57B1 mice (close(i symbols) or CBA mice (open symbols). The lower panel shows
the cytotoxicity to 51Cr labelle(d SDLC cells. All data points represent the arithmetic mean
( standlard error) ofcutltures set up in triplicate.
of polyoma virus transformed fibroblasts,
at which time effector lymphocytes specific
to polyoma tumour antigens exist (as
defined by a macrophage migration in-
hibition assay; Gorczynski, 1974a). In
addition, spleen cells were taken from
5 Balb/c mice given MSV 12 days earlier
and from 4 Balb/c mice inoculated intra-
peritoneally with 50 x 106 C57B1 spleen
cells 18 days earlier. All spleen cell
suspensions were tested for cytotoxic
activity towards 5'Cr-labelled SDLC cells,
L
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as well as 51Cr-CBA or C57B1 spleen
cells. The red cells in the target CBA
or C57B1 spleen preparations were lysed
with Tris buffered ammonium chloride
(Boyle, 1968) before labelling the cells.
The subsequent labelling procedure and
preincubation were as described in the
Materials and Methods for SDLC cells.
Since we have found that even pre-
incubation does not markedly decrease
the spontaneous release from 51Cr-spleen
cells, the assay in this experiment was
performed for only 8 h rather than the
15 h used elsewhere throughout this
communication. The backgroundrelease,
as a percentage of the detergent released
counts for SDLC, CBA and C57B1 cells
for 8 h was 14 i 0 9, 29 + 1-9 and
31 1 2-2 respectively. The data for this
assay are shown in Fig. 2.
It is clear from these data that
neither alloimmune nor polyoma immune
animals contain cytotoxic cells capable
of killing 51Cr-SDLC cells in this assay.
In addition, MSV infected animals which
do have cells cytotoxic for 51Cr-SDLC
cells do not have cells which are simul-
taneously cytotoxic towards 51Cr-spleen
cells of C57B1 or CBA mice. As defined
by these tests, the cytotoxicity measured
is antigen specific. Further data in sup-
port of this contention will be mentioned
later.
In order to investigate the nature
of the MSV immune cytotoxic effector
cells at different times post MSV infection,
we have used the ability of previously
described anti-Br-O and anti-Ig antisera
to kill respectively murine T or B lympho-
cytes (Gorczynski, 1974b). Spleen cells
taken from pools of 4 mice at various
times post MSV infection were left un-
treated or were treated with either anti-
serum with guinea-pig complement, or
with complement alone. Each cell popu-
lation was tested at various ratios for
specific cytotoxicity to 51Cr-SDLC cells.
The data from this experiment, showing
the cytotoxicity at one ratio (100: 1),
are shown in Table I. At all times post
MSVinfectionthe cytotoxicity is mediated
by T lymphocytes (anti-Br-O sensitive
cells). The increase in activity after
treatment with anti-Ig is presumably
due to the increased percentage of T
cells in these preparations (since equi-
valent numbers of viable cells after treat-
ment were tested). These results would
concur with previously reported studies
on the effector cells in other tests of
immunity (Gorczynski, 1974a, b, c) and
with the data of Herberman et al. (1973)
using a 51Cr cytotoxicity test in the
MSV system. They are in marked con-
trast with those of Lamon et al. (1973),
who have evidence for a change in the
nature of the effector cells as a function
of time post MSV infection.
TABLE I.-Effect ofAnti-Br-O and Anti-Ig on Cell Mediated Cytotoxicity
of MSV Spleen Cells to 51Cr-SDLC Cell8
Source of spleen cells
(time post MSV
infection in days)*
0
10
15
20
25
30
Percent specific 51Cr releaset
A- A
Untreated Treated with Treated with Treated with
effector cells anti-Br-O+C' anti-Ig+C' C' only
0 441 4 0 3+0 7 0 7+0 6 0 7+-0 6
35±3 7 2 1±0 6 44±1 5 33+1 3
13±0 6 0-9±0 7 18±0 7 13±2 0
9 5±12 0 5±1 1 13±1 6 10±1i 6
29±0 8 1 6±0 8 37±0 6 30±1 4
19±1-6 2 1±1-3 23±2-0 17±0-8
* 4 mice infected previously with MSV at the times shown were used to prepare the spleen cell pools
under test.
t Arithmetic mean (±standard error) of cultures set up in triplicate, with an effector: target ratio
of 100: 1. Treatment with anti-Br-O. anti-Ig or complement was as described in the text and Materials
and Methods.
28
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Velocity sedimentation analysis of cytotoxic
cells at different times post MSV infection
In order to compare previous data
on the effector cells in other tests of
cell mediated immunity (CMI) to MSV
tumour associated antigens (TAA) (Gor-
czynski, 1974a, b, c) with the current
data investigating cytotoxic cells to SDLC
targets, we have analysed the sedimenta-
tion velocity of effector cells at different
times post MSV infection.
5 x 108 spleen cells (pooled from 5 mice
given MSV at the times shown) were frac-
tionated for 3 h at 4°C. Thirty millilitre
fractions were collected, the cells centri-
fuged (200 g for 5 min at 4°C), resuspended
in 5 ml DF10 and counted. Cells from
each of the fractions shown were tested
at different effector: target ratios with
a constant number (5 x 104) of 5'Cr-
labelled SDLC target cells in a 15 h 51Cr
test, as described previously. All groups
were tested in triplicate. Unfractionated
cells were similarly tested at various
ratios. The data for this experiment are
shown in Fig. 3.
It should be noted that these data
show only the cytotoxicity when a
constant percentage (10%) of the cells
in both fractions were tested with 5 x 104
target cells. This activity profile is a
valid means of comparison provided the
linear dilution curves (effector activity
versus effector cell number) of each cell
population tested do not have widely
different slopes. This was the case for
all experiments (data not shown). It is
interesting that at early times (10 days
post MSV) the majority of the cytotoxic
activity resided in large cells, there being
a gradual shift to smaller cells at late
times post MSV infection. In marked
contrast with earlier data, we did not
find two peaks of effector cell activity.
This is presumably because the suppressor
cells described in earlier reports (Gorczyn-
ski, 1974c) have no effect on cytotoxic
activity, a point already discussed else-
where (Gorczynski et al., 1975). Apart
from this point, however, there is reason-
ably good correlation between effector
cells in a cytotoxic assay and in other
assays of CMI to MSV-TAA.
Specific blocking of cytotoxicity by purified
MSV antigens or MSV sera
In an earlier report we compared the
activity of various sera taken from mice
at different times post MSV inoculation
for their ability to cause specific inhibition
of enhanced DNA synthesis in MSV
immune cells mediated by a tumour
associated cell surface antigen showing
viral group specificity, C-Vgs (Gorczyn-
ski et al., 1975). In Fig. 4 we show
a comparison of the ability of these
sera to block cytotoxicity to 51Cr-SDLC
or 5'Cr-C57BI spleen cells.
Ten Balb/c mice were injected intra-
peritoneally with 5 x 107 C57B1 spleen
cells and 10 days later they were inocu-
lated with MSV in the flank. Ten days
after injection with MSV the mice were
sacrificed, the spleen cells pooled and the
cells tested at various concentrations
with or without a constant concentration
(2%) of serum from the mice given MSV
at the times shown (Fig. 4). For each
cell concentration (in the presence or
absence of serum) the cytotoxicity to
both 51Cr-labelled SDLC and C57B1 spleen
cells was tested. Once again, because
of the high level of background release
with these latter target cells we used
only an 8-h assay for this exp3riment.
The background release as a percentage
of detergent release with SDLC and
C57B1 cells for this period was 13 ± 0*7
and 27 i 1-7 respectively. The data are
shown as a percent blocking (of specific
lysis in the absence of MSV sera) by
2% MSV sera using a 250: 1 effector:
target ratio. The upper panel of this
figure shows the effect of varying the
effector: target cell ratio on the blocking
seen using a given serum (from mice
inoculated with MSV 18 days before-
hand).
The data of this figure show some
interesting features. Firstly, the ability
of sera to inhibit the cytotoxic response
does not correlate well with the peak
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FIG. 3.-Velocity sedimentation profile of cytotoxic cells from MSV immune spleens at different
times post MSV injection (shown above each panel in the figure). The fractions shown were
suspended to the same volume and constant percentages of each fraction tested for their ability
to lyse 51Cr-SDLC cells. All data points are means (±i standard error) oftriplicate determinations
using 5 x 104 target cells and 10% of the cells from each fraction. Data points to the left of
each panel represent unfractionated spleen cells (tested at a 200: 1 ratio).
growth of the tumour or the development
of cells suppressing effector cells in other
tests of CMI (Gorczynski, 1974c). How-
ever, development of serum blocking
factors for this test of CMI parallels
the development of serum blocking factors
for other tests of CMI to MSV-TAA
(Gorczynski et al., 1975). Secondly, the
actual blocking seen- varies predictably
according to the cytotoxicity senii with
the unblocked cells (see upper panel
of this figure). Finally, early progresgsor
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FIG. 4. Specificity of blocking to cytotoxicity (to SDLC or C57B1 spleen cells) by sera taken from
mice at different times post MSV infection. Percent cytotoxicity to SDLC (closed circles) or
C57B1 spleen cells (open circles) was determined in the presence or absence of sera (final concen-
tration in test was 2%) taken from mice at various times post MSV infection (the number of
mice used to prepare each serum pool is shown in brackets in the lower panel of the figure). The
percent blocking of cytotoxicity was determined as:
100 x (I _ Percent specific release in presence of serumj
Percent specific release in absence of serum
The effector cells used in the test were from mice inoculated with 50 x 106 C57B1 spleen cells
20 (lays earlier followed by MSV 10 days later. The upper panel of the figure represents blocking
with various effector cell numbers and a given serum (18 days post MSV). All sera in general
showed similar effects, with the exception of early MSV sera (see figure) which often showed
enhanced cytotoxicity. This is described in detail elsewhere (Gorczynski, in preparation).
The lower panel shows the blocking phenomenon obtained with different sera and a constant
effector target ratio (250 : 1). In the absence of any sera the percent specific cytotoxicity to
SDLC ancl C57BI spleen cells at this effector : target ratio was 32 ± 2 - 2 and 46 + 3 - i respectively.SPECIFIC BLOCKING OF T CELL MEDIATED CYTOTOXICITY
serum (7-11 days post MSV) seems to
enhance the cytotoxic response (see lower
panel ofFig. 4). This effect, which may be
a reflection of antibody mediated cellular
cytotoxicity, will be discussed in a forth-
coming communication.
Our earlier work (Gorczynski et al.,
1975) showed that the blocking activity
seen with 20-day MSV serum was partially
removed by preabsorption of the serum
on an anti-MIG column (see Materials
and Methods). The data of Table II
repeat this finding as well as investigate
the ability of various purified MSV
antigens to block CMI from 11-day
MSV spleen cells. The antigens used in
this test were already shown to stimulate
immune T lymphocytes from MSV re-
gressor mice (Knight and Gorczynski,
1975). Spleen cells were pooled from
4 mice given MSV 11 days earlier and
the percent specific lysis seen with these
cells (and 51Cr-SDLC cells) was compared
in the presence or absence of various
concentrations ofthe antigens (and serum)
under test. The data shown in Table II
represent the blocking of cytotoxicity
at a 100: 1 effector: target ratio in
TABLE II. Serum and Viral Antigen Induced Blocking of Cytotoxicity to
SDLC Cells
Source of blockiing
activity (concentration)*
None
VEA 100 jug/ml
10 jIg/mi
MSV(AM) 100,ug/ml
10 lig/m
MSV(G) 100 ,ug/ml
10 jig/ml
Disrupted AISV(M) 100 jig/ml
10 lig/ml
Disrupted MSV(G) 150 jig/ml
50 jig/ml
Purified p30 protein 140 jug/ml
40 jig/ml
C-Vgs protein 200 jig/ml
50 jig/ml
20-day MSV unabsorbed 20%
serum 0.4%
Anti-MIg column absorbed
Column Equivalent
effluent volumes to
unabsorbed
material
Column Equivalent
absorbed-acid volumes to
eluted unabsorbed
material
Recombined Equivalent
fractions volumes to
unabsorbed
material
Percent specific
51Cr releaset
42±2-1
41±1 8
42+1 9
42+1 1
410 *9
43±1 *2
42+1 *2
33+1 4
39±1 *3
30±1 9
38+1 *8
27±2-1
35+1 *9
19±1 4
32±1 *6
12+1 5
27±2-1
25+2-1
36± 1 *9
23 +417
32+1 5
15±1-5
29 + 1 9
Percent blocking
of specific
5'Cr release:
2
0
0
2
-2
0
21
7
28
9
35
17
55
24
72
36
40
14
45
24
64
31
* All cultures were set up containing 5 x 104 5'Cr-SDLC cells and 5 x 106 MSV spleen cells (from
mice given MSV 11 days earlier). In addition, the incubation medium contained the various factors
shown, whose blocking activity was under test, at two (lifferent concentrations (see Table II). The pre-
paration of all these materials is (described in detail in the text and elsewhere (Knight and Gorezynski,
1975). Twenty-day MSV serum was used before and after absorption on an anti-MIg column. In this
case all column treated materials (i.e. effluent, absorbed and acid-eluted, and the recombined fractions)
were concentrated by vacuum dialysis to their equivalent starting volume prior to test.
t Percent specific 51Cr release from SDLC cells after 15 h of incubation. All figures are arithmetic
means (+ 1 standard error) of 3 cultures.
: Percent blocking of specific 5'Cr release (in the absence of blocking factors) by the blocking factors
shown in the first column.
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a 15 h 51Cr release assay with SDLC
cells.
While cells responsive to whole
MSV(M) and VEA exist at this time after
sensitization (Knight and Gorczynski,
1974), it is clear from Table II that the
cytotoxicity to 5'Cr-labelled SDLC cells
is not blocked by these purified viral
antigens nor by the purified Gross virus
pseudotype of MSV(M), MSV(G). How-
ever, MSV(M) and MSV(G), disrupted
by the detergent Triton X-100, are
roughly equipotent inhibitors of CMC,
suggesting that cytotoxic lymphocytes
recognize internal group specific viral
antigens on the target cell surface. The
major such antigen, p30, purified from
MSV(M), inhibits CMC although we have
not tested higher concentrations of this
antigen to determine whether cytotoxicity
could be totally inhibited. A much more
potent inhibitor was extracted by papain
digestion from SDLC cells themselves
(C-Vgs). These data agree well with
our earlier findings investigating the
relative importance of sensitization to
the respective MSV tumour associated
antigens for in vivo tumour regression
(Gorczynski and Knight, 1975). More-
over, we were able to repeat the findings
of an earlier report that the blocking
activity in 20-day MSV serum could be
absorbed on (and eluted from) an anti-
MIg column (Gorczynski et at., 1975).
With the data showing that blocking
with MSV sera was enhanced when
column effluent and acid eluted material
were recombined (see Table II), we feel
that blocking in these sera is probably
mediated by antigen and/or antigen-
antibody complexes.
Blocking of different populations of effector
cells by 20-day MSV sera
Having described here (Fig. 3) and
elsewhere (Knight and Gorczynski, 1974)
the heterogeneity of effector cells to
MSV-TAA, we were interested in the
ability of these different populations to
be blocked by MSV blocking sera. Ac-
TABLE III.-Ability of C-Vgs and 20-day
MSV Serum to Block Cytotoxicity from
Effector Cells taken from Mice at Dif-
ferentTimespost MSV
Source of
effector cells*
10 days post MSV
16 days post MSV
23 days post MSV
30 days post MSV
Percent
blockingby:
Ratio to 20-day
get 30% (J-Vgs MSV
specific (150 serum
cytotoxicityt ug/ml) (2%)
85 :1 62±2-3 88+3-2 240: 1 68±2-8 5212-8
150: 1 60±3-2 512-7
190 :1 612-8 38+2-4
* Spleen cells were pooled from 4 mice within
each group given MSV at the times shown. The
cells were then tested at various doses for their
cytotoxicity to 5 x 104 51Cr-SDLC cells, in the
presence or absence of the blocking factors shown
in the final two columns.
t Ratio of effector cells (shown in the first
column) to target cells (510r-SDLC cells) to get30%
specific lysis at 15 h.
t Percent blocking of the cytotoxicity caused
by that ratio of cells shown in the 2nd column by
either C-Vgs (at 150 ,g/ml) or 20-day post MSV
serum (at 2 % final concentration). All data points
were determined from triplicate cultures in the
presence or absence of blocking factors and the
standard errors shown were computed from the
variation in both numerator and denominator.
cordingly we performed two types of
experiment.
In the first we took cells from animals
of different times post MSV infection and
investigated the cytotoxicity of these
cells at various effector cell: target cell
ratios in the presence or absence of a
standard concentration of 20-day MSV
serum (2%) or C-Vgs (150 ,ug/ml). The
blocking seen with that ratio of cells
giving the same percent specific cytotoxi-
city in the absence of serum (a function
of different effector: target cell ratios for
the different populations) was then deter-
mined. These data, together with the
respective ratios giving the same cyto-
toxicity (30%) in the unblocked popula-
tion, are indicated in Table III. Whereas
C-Vgs apparently blocks effector cells
from mice at all times post MSV infection,
20-day MSV serum was less able to block
the cytotoxicity of effector cells later in
the response.
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In a second experiment, we fraction-
ated cells by velocity sedimentation from
animals given MSV 12 days earlier and
tested the fractions at different ratios
in the presence or absence of a standard
concentration of 20-day MSV serum (2%)
or C-Vgs (150 ,ug/ml).
10 x 108 spleen cells from mice given
MSV 11 days earlier were sedimented for
4 h at 40C and fractions sedimenting
with the velocities shown in Fig. 5 were
pooled and centrifuged as before. The
recovered cells were resuspended in DF10,
recounted, and cultured with 5 x 104
51Cr-SDLC cells at variouseffector: target
ratios, in the presence and absence of
C-Vgs (150 ,ag/ml) or 20-day MSV serum
(2%). After 15 h the supernatants were
harvested and the percent specific 51Cr
release from the various fractions and
an unfractionated control sample were
calculated as before. The percent block-
ing of this activity was calculated from
that ratio ofcells which, from all fractions,
gave 30% specific release in the absence
of blocking factors. Once again this is
a valid comparison provided (as here)
the titration curves from the respective
fractions are parallel.
The data of Fig. 5 show a good cor-
relation between the ability of both
C-Vgs and 20-day MSV serum to block
the cytotoxicity from different subpopula-
tions of lymphocytes. Nevertheless, the
most interesting feature is the demonstra-
tion that a population of cytotoxic T
lymphocytes (see Table I) exists which is
not appreciably blocked by either serum
or C-Vgs. As in Table III, the inhibition
by serum, where demonstrable, was
generally less than that mediated by
C-Vgs. Since we have shown that at
least some of the serum mediated inhibi-
tion is due to factors which bind to an
anti-immunoglobulin column (Gorczynski
et al., 1975), this suggests that antibody
(perhaps complexes with antigen) is a
less potent blocking reagent than free
TAA. Alternatively, the differences may
be caused by different concentrations of
blocking materials in these preparations.
In view ofthe existence ofa non-blockable
fraction of cytotoxic T lymphocytes in
the spleens of MSV progressor animals
(see Fig. 5) and the decreased ability of
cytotoxic spleen cells of MSV regressor
animals to be blocked (Table III), it is
tempting to speculate that non-blockable
T cells are in some way responsible for
tumour regression.
As a final test of the physiological
relevance of this in vitro demonstration
of blocking of cytotoxic lymphocytes, we
investigated the effect of overnight in-
cubation in DF10 followed by similar
incubation in blocking sera on the cyto-
toxic potential of spleen cells taken from
mice at different times post MSV inocula-
tion. The rationale behind this approach
was as follows: (1) The kinetics ofdevelop-
ment of cytotoxic cells (see Fig. 1)
suggested that some in vivo blocking
of effector cells may be taking place late
in tumour progression (days 15-18); (2)
earlier reports (de Landazuri and Herber-
man, 1972; Gorczynski and Tigelaar,
1975) had suggested that in vivo blocked
cells in different tumour systems become
activated for cytotoxicity after overnight
incubation.
Spleen cells were pooled aseptically
from groups of 5 mice inoculated with
MSV at different times and aliquots of
each pool were tested at different ratios
for their cytotoxicity with 5 x 104 51Cr-
SDLC target cells. The remainder
(6 x 108) of the cells were incubated for
15 h in DF10 in small Marbrook type
culture vessels at a concentration of
2 x 107 cells per ml. After this time
the cultures were harvested, the cells
washed twice in DF10 and aliquots re-
tested for cytotoxicity with 5 x 104
51Cr-SDLC target cells, before and after
treatment with anti-Br-O (see Materials
and Methods). This latter test was per-
formed to check that the cytotoxicity
after overnight incubation in DF10 was
still due wholly to T lymphocytes. The
remainder ofthe harvested cells (1.5x 108)
were divided into 3 pools and 50 x 106
cells of each incubated for a further 15 h
399R. M. GORCZYNSKI AND R. A. KNIGHT
1n0
a)
e)
CZ
a)
Q
U
a)
x ;.
.0
a1)
a)
un a
(O 44
24
1O(
E 8(
0
Cn
p 6C
C" 40
Q0
20
I7r
2 3 4 5 6
Sedimentation Velocity(mm /h)
7
FIG. 5. Blocking of cytotoxicity from velocity sedimentedI -1(lay AISV immune spleeni cells by
C-Vgs (150 ig/ml -upper panel) or 20-day post MSV serum (2°0 finial concentration-lower
panel). The computationi of these data are explainedl in dketail in the text. All points represent
arithmetic means of 3 cultures (in the presence or absence of blocking factors). The standardt
error bars were compute(d taking into account the variation in both the nlumerator and (lenomi-
niator. Data to the left of each panel show the blocking of uinfractionated cells.
in either DF10 or iDF10 containing 1000
normal Balb/c serum or 1000 20-day
post MSV Balb/c serum. After this
time the cells were harvested, washed
twice in DF10 as before and their cyto-
toxic potential with 5 x 104 5'Cr-SDLC
target cells measured once more. The
data from these three time points of
assay are shown in Table IV. At each
time of harvesting the mean recovery
of viable cells (after 15 h) was 55 ± 10%.
The data are expressed as the ratio of
JI
r
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TABLE IV.-Unblocking and Re-blocking of in vivo Blocked MSV Immune Spleen Cells
Source of
effector cells*
10 days post MSV
16 days post MSV
23 days post MSV
30 days post MSV
30 days post MSV
Specific cytotoxic
potentialt
(Day 0)
110 : 1
340 : 1
210 : 1
290 1
Specific cytotoxic potential
after incubation in DFIO
Untreated Anti-Br-O treated
70 :1 0 9±0 5
50 :1 -1-6±0-9
70 :1 0-4+1-8
Specific cytotoxic potential
after incubation in§
10% 10%
normal 20-day
DFIO serum MSV serum
40: 1 45: 1 380: 1
30:1 40:1 300:1
50: 1 60: 1 270: 1
80 : 1 250 : 1
* Effector cells were pooled from groups of 5 mice injected with MSV at the times shown. The cells
were tested at different ratios for their cytotoxicity to 5 x 104 51Cr-labelled SDLC cells.
t Ratio of effector : target cells needed to see 25% specific 51Cr release from 51Cr-SDLC cells, using spleen cells freshly removed from mice (see first column).
t Ratio of effector : target cells needed to see 25% specific 51Cr release from 5'Cr-SDLC cells, using
spleen cells which had been incubated in DF10 for 15 h. The cytotoxicity shown for anti-Br-O + complement
treated incubated cells is for the same ratio of untreated cells giving 25% specific release.
§ Ratio of effector : target cells needed to see 25% specific 51Cr release from 51Cr-SDLC cells, using
spleen cells which were first incubated for 15 h in DFac (see third column) and then were incubated for
a further 15 h in either DFIO or DF10 containing 10% normal serum or 10% 20-day post MSV serum.
effector: target cells needed to produce
25% specific 51Cr release with each pool
of cells, except for the anti-Br-6 treated
cells, where the cytotoxicity seen at
that ratio of untreated cells giving 25%
specific release is shown.
Comparison of the columns of Table
IV reveals some interesting features.
Cytotoxic activities from all pools of cells
tested were increased by incubation in
DF10, as indicated by the lower effector:
target cell ratio needed to produce the
same degree oflysis. Aftertheincubation,
the cytotoxicity remained wholly due to
cytotoxic T lymphocytes. The possibility
that small increases in cytotoxic potential
might be explained by selective survival
of cytotoxic cells (since viable cell re-
covery was only 55 i 10%) must be
borne in mind (see also Gorczynski and
Tigelaar, 1975). The very dramatic in-
crease in activity seen with 16-, 23- and
30-day post MSV-spleen cells, which
now become as active as 10-day post
MSV cells treated similarly, is not, we
feel, explainable by selective survival.
Rather, this is very suggestive of the
" leaching off " of blocking materials
fromthe cell surface duringtheincubation.
The effect of further incubation in
either DF10, normal mouse serum or
blocking serum (see Fig. 4 and 5 and
Tables II and III) was even more striking.
After incubation in 20-day MSV serum
the cytotoxic potential of the cells was
decreased to similar levels to (or even
less than) the initial values obtained
directly after removing the spleen cells
from the intact animals. These data
very strongly argue that the in vivo
blocking effect is mediated by serum
factors. Moreover, since such blocking
was produced in the absence of target
cells, the data suggest that the blocking
factors are either free antigen or antigen-
antibody complexes, each of which would
be capable ofbinding to cytotoxiclympho-
cyte receptors.
DISCUSSION
The main emphasis of this work has
been to analyse the ability of MSV
tumour associated antigens (TAA) to
block the direct cell mediated cytotoxicity
significance of this phenomenon. Our
initial studies suggested that the effector
cells in the cytotoxic assay we employed
(a 15 h 51Cr release assay) were antigen
specific cytotoxic T cells. This was so
irrespective of the time post MSV infec-
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tion at which spleen cells (containing
effector cells) were harvested from immune
mice (Table I and Fig. 2). These results
concur with the studies of Herberman et
al. (1973) who studied immunity to
MSV in C57B1 mice, and with those of
Leclerc et al. (1973), both of whom used
a similar 5'Cr release assay. They do
not agree, however, with the results of
Lamon et al. (1972, 1973) who found in
the MCA evidence for a non-T cytotoxic
cell at late times post MSV. However,
these discrepancies may be related to the
type of assay used for studying CMC, the
surface antigens expressed by the target
cells used and the length ofthe assay.
As defined by velocity sedimentation
(Fig. 3), tumour cell specificity (Fig. 2)
and the effects of an anti-T (rabbit
anti-Br-0) or anti-B (rabbit anti-mouse
immunoglobulin) antiserum (Table I) the
effector cells in the 51Cr release assay
correspond well with those defined in
other tests of CMI in the MSV system
(Gorczynski, 1974a). Moreover, when
purified virally induced TAA were tested
for their ability to inhibit cytotoxicity,
the results substantially confirmed earlier
data on blocking in other tests of CMI
(Gorczynski et al., 1974b) and the relative
importance of defined virally induced
TAA in in vivo tumour rejection (see
Table II and Knight and Gorezynski,
1975). For example, the cell extract,
C-Vgs, was both the most potent in-
hibitor of CMC and the most effective
antigen for sensitizing cells capable, on
adoptive transfer, ofprotecting sublethally
irradiated mice against MSV tumour
challenge (Gorczynski and Knight, 1975).
Similarly, the viral group specific antigen,
p30, inhibited CMC, stimulated blast
transformation by regressor T Jympho-
cytes (Knight and Gorczynski, 1975)
and sensitized cells which, on transfer,
protected against MSV tumour challenge
in vivo. Cell extracts prepared from
tumour induced by several strains of
MLV have also been shown to inhibit
MSV-M immune CMC in a MCA (Plata
and Levy, 1974).
The data of Fig. 4, using spleen cells
from mice sensitized to both MSV-TAA
and to murine alloantigens, indicate that
the blocking mediated by soluble TAA
(C-Vgs) or serum (20-day post MSV
serum see Table II) was antigen specific.
In Table II and elsewhere (Gorczynski et
al., 1975) we found that the serum
mediated inhibition was in part due to
material not absorbed on an anti-MIg
column (free TAA?) and in part to
material absorbed to the column. Far
greater blocking was seen when these two
components were mixed, however, sug-
gesting that the most potent blockade
was mediated by antigen-antibody com-
plexes in antigen excess.
When comparing these data with the
in vivo growth pattern of the tumour,
several anomalies become apparent.
Firstly, cytotoxicity measured by the
CRT by spleen cells from tumour bearing
mice (Days 11-15) was greater than
from late progressors or early regressors
(see Fig. 1). This correlates well with
the development ofserum blocking factors
(Fig. 4) but not with tumour growth.
Secondly, in earlier studies (Gorczynski,
1974c) we described how the CMI (mea-
sured by lymphocyte transformation or
macrophage migration inhibition) de-
creased during the growth phrase of
the tumour, a decrease associated with the
development of a suppressor cell popula-
tion (see also Kirchner et al., 1974;
Kilburn et al., 1974). Yet this was not
the case with CMI measured by 51Cr
release (Fig. 1), nor were factors (antigen-
antibody complexes?) released by these
suppressor cells which could block CMI
in a 51Cr assay, though such factors were
released to block other assays of CMI
(Gorczynski et al., 1975).
To clarify the relationship between in
vivo tumour growth and in vitro CMI, we
tested the effect of antigen and 20-day
immune serum on fractions of spleen
cells prepared by velocity sedimentation,
from mice injected with MSV at one
specific time and on unfractionated spleen
cells from mice injected with MSV at
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different times. We also investigated
the effect of incubating immune cells in
medium before assay and the effect of
antigen and 20-day immune serum on
these in vitro activated cells.
The data from these experiments are
detailed in Tables III and IV and Fig. 5.
In brief, we found that all unfractionated
spleen cells tested showed a similar
response (in terms of facility to be
blocked) to soluble MSV-TAA (C-Vgs),
but a widely different response to serum
blocking factors. In particular, spleen
cells showed a marked decline in their
ability to be blocked at around the time
of tumour regression, and the decrease
was maintained in regressor animals
(Table III). When spleen cells from
MSV progressor animals were fractionated,
a population of cells was identified which
was refractory to blocking by C-Vgs and
serum. It is interesting to note that
this pool of cytotoxic non-blockable T
cells co-sediments with the suppressor
cells earlier described (Gorczynski, 1974c).
This may help to explain why suppressor
cells and their soluble products had no
effect on CMI analysed by a 5'Cr test.
Finally, as described by de Landazuri
and Herberman (1972) for a rat lym-
phoma, we found that Balb/c MSV
regressor animals contained spleen cells
whose cytotoxic potential was markedly
increased by overnight incubation in
medium. However, and equally interest-
ing, the same was also true of MSV late
progressor and early regressor animals
(Table IV). Again, as determined by
treatment with anti-Br-0, the cytotoxic
cells after overnight incubation were T
lymphocytes (see Table IV). The in-
crease in cytotoxic activity after incuba-
tion in vitro could be abolished if the
cells were now reincubated in blocking
serum (Table IV).
Although, therefore, the cytotoxicity
of unfractionated immune spleen cells
taken between 10 and 30 days after
MSV injection can be inhibited by antigen
and by 20-day serum, a subpopulation
can be fractionated by velocity sedi-
mentation which is cytotoxic, but which
is refractory to inhibition by these
reagents. These non-inhibitable lym-
phocytes may indeed be the subpopulation
most relevant to the tumour status of
the animal, particularly from the time
when the animal's serum becomes inhibi-
tory to other cytotoxic cells. Since this
cell population co-sediments with non-T
cells which suppress other parameters
of CMI (Gorczynski, 1974c), however, the
suppressor cell product, rather than in-
hibiting direct cytotoxicity, may bind
to the cytotoxic T cell surface so as to
prevent the binding ofantigen or blocking
serum. There is evidence, however, that
suppressor cells can reduce the protective
effect of MSV regressor T lymphocytes
adoptively transferred to sublethally
irradiated mice (Gorczynski and Norbury,
1974).
We gratefully acknowledge the expert
technical assistance of K. Adams and
C. Norbury.
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